TWD 19.65
(-0.51%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 5.19 Billion TWD | 2.7% |
2022 | 5.05 Billion TWD | 8.78% |
2021 | 4.65 Billion TWD | 23.58% |
2020 | 3.76 Billion TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 5.19 Billion TWD | 260.96% |
2024 Q2 | 1.33 Billion TWD | -74.29% |
2023 Q3 | 1.43 Billion TWD | 24.25% |
2023 FY | 5.19 Billion TWD | 2.7% |
2023 Q4 | 1.43 Billion TWD | 0.0% |
2023 Q2 | 1.15 Billion TWD | 0.0% |
2023 Q1 | 1.15 Billion TWD | -10.59% |
2022 FY | 5.05 Billion TWD | 8.78% |
2022 Q4 | 1.29 Billion TWD | 0.0% |
2021 FY | 4.65 Billion TWD | 23.58% |
2020 FY | 3.76 Billion TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Lytone Enterprise, Inc. | 598.88 Million TWD | -767.653% |
Vetnostrum Animal Health Co., Ltd. | 1.2 Billion TWD | -330.325% |